School of Medicine


Showing 5,051-5,100 of 5,115 Results

  • Hengameh Zahed, MD, PhD

    Hengameh Zahed, MD, PhD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Zahed is a board-certified, fellowship-trained neurologist with the Stanford Medicine Movement Disorders Center. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences.

    She diagnoses and treats a wide range of movement disorders including Parkinson’s disease, Huntington’s disease, essential tremor, dystonia, and ataxia. She creates a personalized treatment plan for each of her patients using a variety of treatment options, including pharmacological and non-pharmacological options, deep brain stimulation (DBS) treatment for Parkinson's disease and tremors, and botulinum toxin injections for movement disorders and spasticity.

    Prior to joining Stanford University, Dr. Zahed completed a neurology residency and fellowship in movement disorders at University of California, San Francisco (UCSF), where she also earned her MD and PhD in biomedical sciences. Dr. Zahed’s research interests include understanding the genetic and electrophysiological underpinnings of movement disorders and investigating applications of wearable technologies to monitor symptoms and improve the quality of life in patients with movement disorders. She also participates in clinical trials of new therapeutics for Parkinson’s disease and other movement disorders.

    Dr. Zahed has published in Movement Disorders, Molecular Genetics & Genomic Medicine, The Journal of Clinical Investigation, American Journal of Human Genetics, Cell, and other peer-reviewed journals. She has presented to her peers at international, national, and regional meetings. These meetings have included the International Congress of Parkinson’s Disease and Movement Disorders, the Hereditary Disease Foundation Symposium, the World Society for Stereotactic and Functional Neurosurgery, and the Society for Neuroscience.

    Dr. Zahed is a member of the International Parkinson and Movement Disorders Society.

  • Aydin Zahedivash

    Aydin Zahedivash

    Adjunct Clinical Assistant Professor, Clinical Informatics

    BioAydin is a pediatrician, educator, and engineer whose interests lie at the intersection of technology, health equity, and children’s health. Aydin completed his undergraduate degree in Biomedical Engineering at the University of Texas at Austin and went on to complete an MD and MBA at the University of Texas at Austin Dell Medical School and McCombs School of Business. He has a keen interest in the medical technology space, having contributed as a researcher, mentor, inventor, and consultant in both the academic and industry settings. He is a general pediatrician at the Palo Alto Medical Foundational San Carlos office and serves as the Medical Director for Digital Patient Experience at Sutter Health. At Stanford, he serves as Assistant Director for Digital Health and AI at the Stanford Mussallem Center for Biodesign where he helps teach the Biodesign for Digital Health and Building for Digital Health courses. His research focuses on the role of wearable devices for as diagnostic monitors in children and how digital health can be used to expand and integrate access to care.

  • Natalie M. Zahr

    Natalie M. Zahr

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Major Laboratories)

    BioNatalie M. Zahr received a graduate education in the basic sciences including the study of neuro- pharmacology, physiology, and anatomy. After completing her graduate training in electrophysiology, she began a postdoctoral fellowship as a magnetic resonance imaging (MRI) scientist. Her work focuses on translational approaches using in vivo MR imaging and spectroscopy in studies of human with Alcohol Use Disorders (AUD) and in rodent models of alcohol exposure with the goal of identifying mechanisms of alcohol effects on the brain. Her human studies include participants with HIV, those co-morbid for HIV and AUD and recently, aging individuals with mild cognitive impairment (MCI). Her position allows her to explore emerging MR technologies and apply them to test relevant hypotheses. Before joining Stanford, she taught at several local institutions including UC Berkeley extension and Santa Clara University where she enjoyed sharing her knowledge and enthusiasm for learning with students.

  • Yulia Zak, MD, FACS

    Yulia Zak, MD, FACS

    Clinical Assistant Professor, Surgery - General Surgery

    BioDr. Yulia Zak is a board-certified, fellowship-trained minimally invasive and bariatric (weight loss) surgeon. She is also a clinical assistant professor of surgery at Stanford University School of Medicine. Dr. Zak is the program director and unit-based medical director for the Minimally Invasive, Bariatric, and Foregut Fellowship Program.

    Dr. Zak specializes in bariatric surgery, foregut (upper digestive tract) surgery, and abdominal wall procedures. Her research is focused on quality improvement measures, surgical education, and bariatric surgery outcomes. She has published her work in numerous peer-reviewed journals, including Obesity Surgery and the Journal of the American College of Surgeons.

    Dr. Zak is a fellow of the American College of Surgeons.

  • Sandra Zaky

    Sandra Zaky

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    BioDr. Zaky is a board certified Radiation Oncologist. She received a Bachelor’s of Science in Biomedical/Electrical Engineering at Marquette University. She worked in research and development as an Engineer, and eventually received a Masters of Science in Immunology from Albany Medical College. Her research thesis focused on a novel therapy to treat hormone-receptor positive breast cancer. She continued to study breast cancer with her research during her Radiation Oncology residency; she integrated her research in the laboratory with her clinical research in triple-negative breast cancer. Since completing residency, she has worked as a general radiation oncologist, and her special interests include breast cancer, skin cancer, CNS tumors and stereotactic radiotherapy.

  • Isheeta Zalpuri

    Isheeta Zalpuri

    Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioDr. Isheeta Zalpuri is a Clinical Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She serves as Program Director for the Child and Adolescent Psychiatry Fellowship, where she is dedicated to advancing exceptional clinical training and supporting the professional growth of future child and adolescent psychiatrists. With a strong foundation in educational pedagogy, Dr. Zalpuri uses innovative, learner-centered teaching methods to create engaging, inclusive, and effective learning environments for students, residents, fellows, and faculty. Her longstanding commitment to excellence in education has been recognized through numerous teaching and mentorship awards.

    As Associate Chair for Clinical Educator Professional Development, Dr. Zalpuri is invested in strengthening faculty development efforts across the department. Her work focuses on creating meaningful opportunities for mentorship, sponsorship, leadership development, and career advancement among clinical educators.

    Clinically, Dr. Zalpuri specializes in Pediatric Anxiety Disorders and Obsessive-Compulsive Disorder. She provides compassionate, evidence-based care for children, adolescents, and families while remaining at the forefront of evolving treatment approaches. She is extensively published in the areas of child and adolescent mental health, medical education, and professional development.

  • Roham Zamanian

    Roham Zamanian

    James and Yvonne Wood Professor of Pulmonary Vascular Medicine

    Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.

    2. Prevalence and Treatment of Insulin Resistance in PAH.

    3. Role of inflammation and proteomic signature in PAH

    4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.

    5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension

    6. Assessment of microvascular function in PAH.

  • Richard Zare

    Richard Zare

    Marguerite Blake Wilbur Professor of Natural Science and Professor, by courtesy, of Physics

    Current Research and Scholarly InterestsMy research group is exploring a variety of topics that range from the basic understanding of chemical reaction dynamics to the nature of the chemical contents of single cells.

    Under thermal conditions nature seems to hide the details of how elementary reactions occur through a series of averages over reagent velocity, internal energy, impact parameter, and orientation. To discover the effects of these variables on reactivity, it is necessary to carry out studies of chemical reactions far from equilibrium in which the states of the reactants are more sharply restricted and can be varied in a controlled manner. My research group is attempting to meet this tough experimental challenge through a number of laser techniques that prepare reactants in specific quantum states and probe the quantum state distributions of the resulting products. It is our belief that such state-to-state information gives the deepest insight into the forces that operate in the breaking of old bonds and the making of new ones.

    Space does not permit a full description of these projects, and I earnestly invite correspondence. The following examples are representative:

    The simplest of all neutral bimolecular reactions is the exchange reaction H H2 -> H2 H. We are studying this system and various isotopic cousins using a tunable UV laser pulse to photodissociate HBr (DBr) and hence create fast H (D) atoms of known translational energy in the presence of H2 and/or D2 and using a laser multiphoton ionization time-of-flight mass spectrometer to detect the nascent molecular products in a quantum-state-specific manner by means of an imaging technique. It is expected that these product state distributions will provide a key test of the adequacy of various advanced theoretical schemes for modeling this reaction.

    Analytical efforts involve the use of capillary zone electrophoresis, two-step laser desorption laser multiphoton ionization mass spectrometry, cavity ring-down spectroscopy, and Hadamard transform time-of-flight mass spectrometry. We believe these methods can revolutionize trace analysis, particularly of biomolecules in cells.

  • Christopher K. Zarins

    Christopher K. Zarins

    Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery, Emeritus

    Current Research and Scholarly InterestsDiagnosis of coronary artery disease using coronary CT angiography with AI-enabled quantitation of coronary plaque burden and lesion-specific coronary ischemia is used to guide management of CAD. Applying this strategy to PAD patients with no cardiac symptoms reveals a high prevalence of silent coronary ischemia. Ischemia-targeted coronary revascularization may to reduce death and MI and improve long-term survival. Randomized trials in carotid and peripheral vascular patients are underway .

  • James L. Zehnder, M.D.

    James L. Zehnder, M.D.

    Professor of Pathology (Research) and of Medicine (Hematology)

    Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.

  • Mira Zein

    Mira Zein

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
    Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population Health

    BioDr. Zein received her dual bachelor’s degrees in Anthropology and Physiological Science at UCLA and worked initially as a healthcare consultant, developing programs that improve healthcare access for vulnerable populations. She returned to school to pursue a Masters in Public Health at Johns Hopkins University; her research foci were disaster response interventions for physical and mental health and the impact of the built environment on public health. During her masters, she worked with the International Rescue Committee in Baltimore to help address the acculturation and psychological stress the Baltimore refugee population faced in resettlement.

    Dr. Zein completed her medical training at McGill University. During medical school she continue to pursue interests in global and cultural health, focusing on national and local clinical projects to support refugee and asylum seeker access to medical and mental health treatment as part of CFMS. She was awarded the Mona Bronfman Sheckman Prize in Psychiatry for her work. During her psychiatry residency training at New York University (NYU), Dr. Zein continued pursuing her interest in global mental health, working as a group leader for refugees/asylum seekers in the Bellevue Survivors of Torture program, and the Association for Culture and Psychiatry.

    She also became interested in models of Integrated Behavioral Health (IBH) to provide better access to mental health services within primary care and other settings. She founded the Integrated Behavioral Health resident working group and designed a two-year resident training program in the Collaborative Care Model, and developed a Collaborative Care model in one of NYU Langone-Brooklyn's FQHC sites. She completed residency as a chief resident and won awards for Excellence in Resident Teaching as well as for humanism and clinical excellence in the Comprehensive Psychiatric Emergency Program

    Dr. Zein completed her Consult Liaison Fellowship at Stanford and has remained as clinical faculty. She previously currently served as an attending psychiatrist on the General, Intensive Care, and ED-Psychiatry Consult service. She currently works as the Psychiatric Director for Integrated Behavioral Health. She initially the model for the Stanford Primary Care Clinic serving Cisco employees and their families. She is currently working on expanding Integrated Behavioral health to other Stanford Primary Care Clinics, and has worked with Stanford's Digital Health Team to start and expand psychiatry e-consults for primary care. She also works as the Behavioral Health Director for Cisco, applying principles of organizational psychiatry and public health to assess company behavioral health strategy and provide support for Cisco employees and their families. Additionally, Dr Zein is part of the Stanford Mental Health lab where she supervises and completes evaluations for refugee and asylum seekers, and teaches Neuroscience and Psychopharmacology for the Psychiatry Residents

  • Michael Zeineh

    Michael Zeineh

    Professor of Radiology (Neuroimaging and Neurointervention)

    BioDr. Michael Zeineh received a B.S. in Biology at Caltech in 1995 and obtained his M.D.-Ph.D. from UCLA in 2003. After internship also at UCLA, he went on to radiology residency and neuroradiology fellowship both at Stanford. He has been faculty in Stanford Neuroradiology since 2010. He spearheads many initiatives in advanced clinical imaging at Stanford, including clinical fMRI and DTI. Simultaneously, he runs a lab with the goal of discovering new imaging abnormalities in neurodegenerative disorders, with a focus on detailed microcircuitry in regions such as the hippocampal formation using advanced, multi-modal in vivo and ex vivo methods, with applications to neurodegenerative disorders such as Alzheimer’s disease and mild traumatic brain injury.

  • Jamie Zeitzer, PhD

    Jamie Zeitzer, PhD

    Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsDr. Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.
    He examines the manner in which humans respond to light and ways to manipulate this responsiveness, with direct application to jet lag, shift work, and altered sleep timing in teens. Dr. Zeitzer has also pioneered the use of actigraphy in the determination of epiphenomenal markers of psychiatric disorders.

  • Bing Melody Zhang

    Bing Melody Zhang

    Clinical Professor, Pathology

    Current Research and Scholarly InterestsMy main research interests lie in the following areas:
    1) HLA testing for BMT/solid organ transplantation/cellular therapy/oncology
    2) Comprehensive cancer genomics testing
    3) NGS-based TCR/Ig clonality/MRD testing
    4) HLA-related disease association/drug hypersensitivity testing

  • Fanglin Zhang, MD., PhD.

    Fanglin Zhang, MD., PhD.

    Clinical Associate Professor, Adult Neurology

    BioDr. Zhang is a Clinical Associate Professor of Neurology and Neurological Sciences at Stanford University, where she provides comprehensive inpatient and outpatient care for patients with complex neurological disorders. She is a board-certified neurologist and fellowship-trained clinical neurophysiologist. Dr. Zhang is committed to delivering patient-centered, evidence-based care and building strong partnerships with her patients to improve neurological health and quality of life. Her approach emphasizes collaboration, communication, and shared decision-making, ensuring that patients are actively engaged in their care.
    As a dedicated clinician-educator, Dr. Zhang is passionate about mentoring the next generation of physicians. She serves as the Site Director for the Stanford Neurology Residency Program and the Neurohospitalist Fellowship Program at Stanford Health Care Tri-Valley, and as the Education Director of Stanford Health Care Tri-Valley Neurology. She is also deeply committed to community service and global health.
    Dr. Zhang has published extensively in peer-reviewed journals and is committed to advancing innovative clinical research. Her current research focuses on leveraging artificial intelligence and clinical informatics to improve neurological disease prevention, optimize clinical decision-making, and enhance the delivery of neurological care.

  • Hao Zhang

    Hao Zhang

    Clinical Assistant Professor, Radiation Oncology - Radiation Physics

    Current Research and Scholarly Interests- Artificial Intelligence for Medical Imaging
    - Novel Imaging Systems
    - Medical Image Reconstruction, Segmentation, Registration, and Analysis
    - Image-Guided Radiation Therapy
    - Motion Management in Radiation Therapy

  • Huaiyu Zhang

    Huaiyu Zhang

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine
    Clinical Assistant Professor (By courtesy), Psychiatry and Behavioral Sciences

    BioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.

  • Ke-You (Yoyo) Zhang

    Ke-You (Yoyo) Zhang

    Clinical Assistant Professor, Pediatrics - Gastroenterology

    BioDr. Ke-You "Yoyo" Zhang is a board-certified pediatric transplant hepatologist and clinical assistant professor at Stanford University School of Medicine. She serves as Medical Director of both the Intestinal Transplant Program at Lucile Packard Children’s Hospital and the Vascularized Composite Tissue Transplant Program at Stanford Hospital. Dr. Zhang specializes in pediatric intestinal and liver transplantation, with research interests at the intersection of transplant immunology, stem cell therapeutics, and precision medicine.

    A graduate of the University of Connecticut School of Medicine, Dr. Zhang completed her pediatrics residency and fellowships in pediatric gastroenterology and transplant hepatology at Stanford. She has authored numerous peer-reviewed publications on topics including pediatric liver and intestinal transplantation, acute rejection, and pancreatitis, and she is a frequent invited speaker at international conferences. Dr. Zhang also directs clinical trials advancing novel therapies for intestinal transplant patients and holds leadership roles in national transplant and hepatology societies.

    Her work is recognized with the 2025 Early Career Clinical Excellence Award from Stanford's Department of Pediatrics. Dr. Zhang is deeply committed to improving outcomes and quality of life for children with complex gastrointestinal and liver diseases through innovative, multidisciplinary care.

  • Niushen Zhang

    Niushen Zhang

    Clinical Associate Professor, Adult Neurology

    BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.

    Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University.

  • Ray Rui Zhang

    Ray Rui Zhang

    Adjunct Clinical Instructor, Radiology - Rad/Nuclear Medicine

    BioBackground:

    Ray Zhang grew up in Chicago, Illinois. He attended to UC Berkeley, where he majored in Chemical Biology. He then joined the Medical Scientist Training Program at the University of Wisconsin - Madison School of Medicine and Public Health, and earned his combined MD and PhD degrees. He completed his doctoral studies in the field of molecular imaging in the laboratories of Jamey Weichert and John Kuo, developing novel radiotracers for targeted cancer imaging and therapy.

    His career interest involves continued leadership, activism, and translational research in the area of molecular imaging and therapy.

    -------------------------------

    Education and Training:

    Stanford University Medical Center, Palo Alto CA
    Resident Physician, Department of Radiology (2020 - present)

    Loyola Medical Center, Maywood IL
    Resident Physician, Internal Medicine (6/2019-6/2020)

    University of Wisconsin, Madison WI
    M.D. (7/2011-5/2019)

    Ph.D. Cellular and Molecular Biology (8/2013 – 6/2017)
    Dissertation: Next Generation Alkylphosphocholine Analogs for Multimodality Imaging and Therapy of Cancer
    Advisor: Jamey Weichert, Ph.D., John Kuo, M.D., Ph.D., F.A.C.S.
    Project: Synthesis, characterization and preclinical imaging of tumor-targeted platform agents for intraoperative fluorescence-guided surgery, positron emission tomography, magnetic resonance imaging, and targeted radiotherapy

    University of California, Berkeley CA
    B.S., Highest Honors, Chemical Biology (2006 – 2009)
    William C. Braye Scholar 2006-2009

    ----------------------------------

    Honors and Leadership Positions:

    Lovell Memorial Scholarship for Excellence in Academic Radiology (2019)
    Department of Radiology, University of Wisconsin. Madison, WI

    Seminar Chair, Medical Scientist Training Program (2014-2015)
    University of Wisconsin. Madison, WI

    Keynote Speaker at Gray Matters Fundraiser Event
    Foundation in Support for Brain Cancer. Madison WI (2014)

    Secretary, Asian Pacific American Medical Student Association (2013-2014)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Treasurer, Asian Pacific American Medical Student Association (2012-2013)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Medical Scientist Training Program (2011-2019)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Co-founder, American Physician Scientist Association, Wisconsin Chapter (2013-2014)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Treasurer, American Physician Scientist Association, Wisconsin Chapter (2013-2014)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Teaching Assitant/Mentorship Achievement Award in Biological Sciences (2014)
    Department of Cellular and Molecular Biology. University of Wisconsin-Madison

    SPARK Research Fellow, H. Lee Moffitt Cancer and Research Institute (2007-2008)
    Moffitt Cancer Center, Tampa, FL

    Highest Honors in Chemical Biology (2009)
    University of California, Berkeley

    Dean’s List (2006-2009)
    University of California, Berkeley

    William C. Braye Scholarship for Excellence in Chemistry (2006-2009)
    University of California, Berkeley

    --------------------------

    Publications/Patents:

    https://scholar.google.com/citations?user=yfG6A8MAAAAJ&hl=en

  • Tian Yi Zhang, MD, PhD

    Tian Yi Zhang, MD, PhD

    Assistant Professor of Medicine (Hematology)

    BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.

    In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.

    Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).

    She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.

    Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.

    She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.

    Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies.

  • Xue Zhang

    Xue Zhang

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Xue Zhang is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. She received her PhD in Biomedical Engineering from Tsinghua University in 2019 and completed research training in neuroimaging and translational psychiatry at Stanford.

    Dr. Zhang’s research focuses on how individual differences in brain circuits contribute to psychiatric symptoms and treatment response. Working at the intersection of neuroimaging, computational neuroscience, and precision psychiatry, she uses functional MRI and data-driven approaches to study brain mechanisms underlying depression, PTSD, and related conditions.

    A major focus of her work is understanding how rapid-acting therapeutics, including ketamine, MDMA, and psilocybin, acutely and durably modulate brain activity and connectivity. Her long-term goal is to develop personalized neuroimaging markers that can help match patients to the treatments most likely to benefit them.

  • Yu Zhang

    Yu Zhang

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.

    Dr. Zhang has received multiple grants including the NIH R01, R21, Eagles Autism Foundation Translational Grant, Alzheimer's Association Research Grant (AARG), and the Knight Initiative for Brain Resilience and the Rosenkranz Foundation Grants. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.

    The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases.

  • Yuan Zhang

    Yuan Zhang

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioYuan Zhang, MD is a board certified family physician who enjoys providing both pediatric and adult care in disease screening, prevention, diagnosis, and treatment, including performing common office procedures. She has special interests in preventative medicine, women's health, and pediatric and adolescent health. She firmly believes that continued clinical excellence is rooted in lifelong learning - both from up-to-date clinical guidelines and from the lived experiences of her patients. She strives to deliver evidence-based care that is also compassionate and patient-centered.

  • Haoqi (Nina) Zhao

    Haoqi (Nina) Zhao

    Assistant Professor of Civil and Environmental Engineering

    BioNina joined Stanford CEE as an Assistant Professor in Summer 2026. Her research bridges computational metabolomics and exposomics to uncover unknown lifestyle chemicals and their impacts on health. Nina earned her B.S. from Peking University, her Ph.D. from the University of Washington, and was a postdoctoral scientist at UC San Diego. She received the Pathway to Independence Award (K99/R00) from the National Institutes of Health in 2025.

    The Zhao Lab at Stanford will operate at the interface of environmental chemistry, environmental health, and computational mass spectrometry. We aim to identify previously unrecognized chemical drivers that influence human and ecosystem health. We pursue this goal by developing innovative computational and analytical methods centered around untargeted mass spectrometry. Through these efforts, we aim to enable precision environmental health strategies, inform public health policies, and inspire sustainable chemical design.

    Current research interests include (but are not limited to):
    1.Leveraging mass spectrometry data repositories and advanced informatics tools to systematically map the chemical exposome.
    2.Developing tools and resources for mass spectrometry data analysis to advance exposomics research.
    3.Investigating host-microbiome-xenobiotic interactions and their impacts on human health.
    4.Integrating toxicology with untargeted screening to accelerate the discovery and risk assessment of unknown molecules.
    5.Pediatric environmental health: chemical exposures through breastfeeding and their implications for infant development.
    6.Traffic-related chemical pollution: environmental fate, occurrence, and relevance to human exposures.

  • Renee Zhao

    Renee Zhao

    Assistant Professor of Mechanical Engineering and, by courtesy, of Bioengineering and of Materials Science and Engineering

    BioRuike Renee Zhao is an Assistant Professor of Mechanical Engineering at Stanford University, where she directs the Soft Intelligent Materials Laboratory. Originally from the historic city of Xi'an, she earned her BS from Xi'an Jiaotong University in 2012. She then pursued Solid Mechanics at Brown University, obtaining her MS in 2014 and PhD in 2016. Following her doctoral studies, she completed postdoctoral training at MIT (2016–2018) before serving as an Assistant Professor at The Ohio State University (2018–2021).

    Renee’s research focuses on developing stimuli-responsive soft composites for multifunctional robotic systems with integrated shape-changing, assembly, sensing, and navigation capabilities. By integrating mechanics, material science, and advanced material manufacturing, her work enables innovations in soft robotics, miniaturized biomedical devices, robotic surgery, origami systems, active metamaterials, and general deployable morphing structures.

    Her contributions have been recognized with honors and awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE), DARPA Young Faculty Award (YFA, 2025), ARO Early Career Program (ECP) Award (2023), AFOSR Young Investigator Research Program (YIP) Award (2023), Eshelby Mechanics Award for Young Faculty (2022), ASME Henry Hess Early Career Publication Award (2022), ASME Pi Tau Sigma Gold Medal (2022), ASME Applied Mechanics Division Journal of Applied Mechanics Award (2021), NSF CAREER Award (2020), and ASME Applied Mechanics Division Haythornthwaite Research Initiation Award (2018). She is also recognized as a National Academy of Sciences Kavli Fellow and was named one of MIT Technology Review's 35 Innovators Under 35.

  • Moss Zhao

    Moss Zhao

    Instructor, Neurosurgery

    BioDr. Moss Zhao is an Instructor at Department of Neurosurgery, Stanford University. He develops cutting-edge and clinically viable imaging technologies to improve the diagnosis and treatment of cerebrovascular diseases across the lifespan. His specific areas of expertise include physiological modeling, arterial spin labeling, Bayesian inference, PET/MRI, and artificial intelligence. His scientific contributions could significantly improve the early detection of strokes and dementia as well as enrich the knowledge of brain development in the first two decades of life.

    Dr. Zhao received his DPhil at St Cross College of University of Oxford under the supervision of Prof. Michael Chappell. As an alumni mentor, he supports the career development of students of his alma mater. Since 2016, he has presented his work to more than 3000 delegates at international conferences and held leadership positions in professional societies. His research and teaching are supported by the American Heart Association, the National Institutes of Health, and the European Cooperation in Science and Technology.

  • Anna Ting Zhou

    Anna Ting Zhou

    Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Anna Ting Zhou is a board-certified, fellowship-trained plastic surgeon with Stanford Health Care. She is also a clinical assistant professor in the Department of Surgery, Division of Plastic & Reconstructive Surgery at Stanford University School of Medicine.

    Dr. Zhou performs a wide range of plastic and reconstructive surgeries to restore both function and appearance for patients affected by cancer and trauma. She specializes in breast reconstruction following breast-conserving surgery (lumpectomy) and mastectomy, offering the full spectrum of reconstruction options. Dr. Zhou also specializes in advanced surgical techniques to prevent and treat lymphedema. She performs procedures such as immediate lymphatic reconstruction, lymphovenous bypass, and vascularized lymph node transfer, helping restore lymphatic drainage and improve patients' quality of life.

    A patient-centered approach guides Dr. Zhou’s practice. She believes that successful reconstruction begins with listening carefully to each patient's concerns, understanding their goals, and working together to develop a personalized surgical plan. She is dedicated to delivering compassionate, evidence-based care and partnering with each patient throughout their reconstructive journey.

    Dr. Zhou's research focuses on advancing reconstructive microsurgery and improving outcomes in breast reconstruction and lymphedema surgery. Her work has explored techniques to preserve breast sensation following mastectomy and novel methods of hybrid breast reconstruction. She has also investigated the use of a medical implant to augment lymphedema surgery and how to optimize lymphedema treatment algorithms. She has authored numerous peer-reviewed publications in leading journals, including Plastic and Reconstructive Surgery, Journal of Surgical Oncology, and Journal of Clinical Medicine, and has presented her research at national and international scientific meetings.

    Dr. Zhou is an active member of the American Society of Plastic Surgeons, the California Society of Plastic Surgeons, and the American Society for Reconstructive Microsurgery.

  • Maggie Zhou

    Maggie Zhou

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Zhou is a Clinical Assistant Professor in the Division of Oncology at Stanford University with a research and clinical focus in sarcoma. She graduated from Yale University with a B.A. and double majored in economics and molecular, cellular, and developmental biology. She subsequently received her M.D. from Stanford University School of Medicine, where she completed her internal medicine residency and fellowship training.

    Her research interests center around the development of novel therapeutics, understanding pathophysiology of rare sarcoma subtypes, and evaluating the utility of circulating tumor DNA for assessing disease response and detecting minimal residual disease. She has co-authored over 20 peer-reviewed publications, including in Clinical Cancer Research and Nature Cell, and is an active member of the Sarcoma Clinical Trial Working Group in the Hoosier Cancer Research Network. Her research has been supported by the Chinese American Hematologist and Oncologist Network and Sarcoma Alliance for Research through Collaboration.

  • Margaret J. Zhou, MD, MS

    Margaret J. Zhou, MD, MS

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Margaret Zhou is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. She also holds an appointment as clinical assistant professor at Stanford University School of Medicine.

    She specializes in therapeutic endoscopy with expertise in treating Barrett’s esophagus and disorders of the pancreas and bile duct. In particular, she offers advanced endoscopic interventions to prevent, detect, and manage gastrointestinal (GI) cancers. These interventions include endoscopic mucosal resection, endoscopic ablation, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasound. She is also interested in the management of esophageal disorders such as gastroesophageal reflux disease.

    Dr. Zhou has published widely on improving the detection of precancerous lesions and cancers of the GI tract. She is particularly interested in prevention, early detection, and outcomes in Barrett’s esophagus, esophageal cancer, and stomach cancer. In addition, she has published on new technologies and the use of artificial intelligence in GI. Her research has been published in multiple journals including Clinical Gastroenterology and Hepatology; Clinical and Translational Gastroenterology; and Cancer Epidemiology, Biomarkers & Prevention.

    Dr. Zhou is an active member of multiple national GI societies. She currently serves on the American Gastroenterological Association (AGA) Clinical Guidelines Committee and AGA Trainee and Early Career Committee. She also serves as an Associate Editor for Evidence-Based GI, an American College of Gastroenterology (ACG) journal.

  • Wenhui Zhou

    Wenhui Zhou

    Adjunct Clinical Instructor, Radiology

    BioWenhui was born in Southeast China and then immigrated to the San Francisco Bay Area as a teenager. He attended the University of California, Davis under a Regent Scholarship, and graduated with highest honors in Biochemistry and Molecular Biology. Wenhui subsequently pursued training in medicine and translational research in the Medical Scientist Training Program (MSTP) at Tufts University. In the Laboratory of Dr. Charlotte Kuperwasser, Wenhui studied the regulation and function of transcription factors in triple-negative breast cancer with the goal of improving cancer diagnosis and therapeutics. Additionally, he pursued clinical research examining image-guided ablative therapy as a front-line treatment option for renal cancer under the mentorship of Dr. Ronald Arellano at Massachusetts General Hospital. Outside of his clinical and academic interests, Wenhui enjoys food, taking walks, listening to NPR, and spending time with family and friends.